| Product Code: ETC10709298 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Uganda Opioid Use Disorder Market Overview |
3.1 Uganda Country Macro Economic Indicators |
3.2 Uganda Opioid Use Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Uganda Opioid Use Disorder Market - Industry Life Cycle |
3.4 Uganda Opioid Use Disorder Market - Porter's Five Forces |
3.5 Uganda Opioid Use Disorder Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Uganda Opioid Use Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Uganda Opioid Use Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Uganda Opioid Use Disorder Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 Uganda Opioid Use Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and recognition of opioid use disorder as a significant public health issue in Uganda |
4.2.2 Growing availability and accessibility of opioid addiction treatment services and programs |
4.2.3 Rising incidence of opioid misuse and addiction among the population |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources for effectively addressing opioid addiction in Uganda |
4.3.2 Stigma and lack of understanding surrounding opioid use disorder leading to underreporting and undertreatment |
4.3.3 Regulatory challenges and gaps in policies governing the use and distribution of opioids in the country |
5 Uganda Opioid Use Disorder Market Trends |
6 Uganda Opioid Use Disorder Market, By Types |
6.1 Uganda Opioid Use Disorder Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Uganda Opioid Use Disorder Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Uganda Opioid Use Disorder Market Revenues & Volume, By Medication-Assisted Treatment (MAT), 2021 - 2031F |
6.1.4 Uganda Opioid Use Disorder Market Revenues & Volume, By Behavioral Therapy, 2021 - 2031F |
6.1.5 Uganda Opioid Use Disorder Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.1.6 Uganda Opioid Use Disorder Market Revenues & Volume, By Support Programs, 2021 - 2031F |
6.2 Uganda Opioid Use Disorder Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Uganda Opioid Use Disorder Market Revenues & Volume, By Buprenorphine, 2021 - 2031F |
6.2.3 Uganda Opioid Use Disorder Market Revenues & Volume, By Methadone, 2021 - 2031F |
6.2.4 Uganda Opioid Use Disorder Market Revenues & Volume, By Naltrexone, 2021 - 2031F |
6.2.5 Uganda Opioid Use Disorder Market Revenues & Volume, By Naloxone, 2021 - 2031F |
6.3 Uganda Opioid Use Disorder Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Uganda Opioid Use Disorder Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Uganda Opioid Use Disorder Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Uganda Opioid Use Disorder Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.3.5 Uganda Opioid Use Disorder Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4 Uganda Opioid Use Disorder Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Uganda Opioid Use Disorder Market Revenues & Volume, By Long-Term, 2021 - 2031F |
6.4.3 Uganda Opioid Use Disorder Market Revenues & Volume, By Outpatient, 2021 - 2031F |
6.4.4 Uganda Opioid Use Disorder Market Revenues & Volume, By Residential, 2021 - 2031F |
6.4.5 Uganda Opioid Use Disorder Market Revenues & Volume, By Harm Reduction, 2021 - 2031F |
7 Uganda Opioid Use Disorder Market Import-Export Trade Statistics |
7.1 Uganda Opioid Use Disorder Market Export to Major Countries |
7.2 Uganda Opioid Use Disorder Market Imports from Major Countries |
8 Uganda Opioid Use Disorder Market Key Performance Indicators |
8.1 Number of individuals enrolled in opioid addiction treatment programs |
8.2 Rate of successful outcomes and recovery among patients undergoing opioid addiction treatment |
8.3 Availability and utilization of harm reduction services for individuals with opioid use disorder |
9 Uganda Opioid Use Disorder Market - Opportunity Assessment |
9.1 Uganda Opioid Use Disorder Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Uganda Opioid Use Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Uganda Opioid Use Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Uganda Opioid Use Disorder Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10 Uganda Opioid Use Disorder Market - Competitive Landscape |
10.1 Uganda Opioid Use Disorder Market Revenue Share, By Companies, 2024 |
10.2 Uganda Opioid Use Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |